Abbreviations used in this paper: DESS = double echo steady state; EMG = electromyography; MRN = MR neurography; NCS = nerve conduction studies; STIR = short tau inversion recovery.
M anageMent of peripheral nerve disease is often challenged by the characterization and localization of the underlying disease process. The current gold standard for the diagnosis of peripheral nerve disease in addition to the neurological examination is needle EMG and associated NCS. 11 New technology continues to emerge which may serve to supplement the currently available diagnostic techniques.
Magnetic resonance neurography is a novel imaging technique in which STIR sequences are used to image spinal and peripheral nerves directly. 3 Magnetic resonance neurography is a tissue-selective imaging modality that reveals not only the morphological characteristics of nerves (including caliber, continuity, and relationships to other nerves and adjacent bone or muscle structures), but also provides information on pathological processes including nerve fibrosis, inflammation, and edema (seen as enhancement or increased signal intensity). A number of studies have investigated the use of MRN to evaluate peripheral nerves. 4, 7 Abnormally high signal in nerve fascicles correlated well with abnormal findings on EMG and NCS demonstrating traumatic nerve injury, compression neuropathy, and tumors of the peripheral nerves. 6, 7 We report the initial diagnostic experience at the UniMagnetic resonance neurography for the evaluation of peripheral nerve, brachial plexus, and nerve root disorders
Object. Treatment of spinal and peripheral nerve lesions relies on localization of the pathology by the use of neurological examination, spinal MR imaging and electromyography (EMG)/nerve conduction studies (NCSs). Magnetic resonance neurography (MRN) is a novel imaging technique recently developed for direct imaging of spinal and peripheral nerves. In this study, the authors analyzed the role of MRN in the evaluation of spinal and peripheral nerve lesions.
Methods. Imaging studies, medical records, and EMG/NCS results were analyzed retrospectively in a consecutive series of 191 patients who underwent MRN for spinal and peripheral nerve disorders at the University of California, San Francisco between March 1999 and February 2005. Ninety-one (47.6%) of these patients also underwent EMG/NCS studies.
Results. In those who underwent both MRN and EMG/NCS, MRN provided the same or additional diagnostic information 32 and 45% of patients, respectively. Magnetic resonance neurograms were obtained at a median of 12 months after the onset of symptoms. The utility of MRN correlated with the interval between the onset of symptoms to MRN. Twelve patients underwent repeated MRN for serial evaluation. The decrease in abnormal signal detected on subsequent MRN correlated with time from onset of symptoms and the time interval between MRN, but not with resolution of symptoms. Twenty-one patients underwent MRN postoperatively to assess persistent, recurrent, or new symptoms; of these 3 (14.3%) required a subsequent surgery.
Conclusions. Magnetic resonance neurography is a valuable adjunct to conventional MR imaging and EMG/ NCS in the evaluation and localization of nerve root, brachial plexus, and peripheral nerve lesions. The authors found that MRN is indicated in patients: 1) in whom EMG and traditional MR imaging are inconclusive; 2) who present with brachial plexopathy who have previously received radiation therapy to the brachial plexus region; 3) who present with brachial plexopathy and have systemic tumors; and 4) in patients under consideration for surgery for peripheral nerve lesions or after trauma. Magnetic resonance neurography is limited by the size of the nerve trunk imaged and the timing of the study. 
Methods

Patient Population
We analyzed data obtained in a consecutive series of 191 patients who underwent MRN at the University of California San Francisco between March 1999 and February 2005. The study was approved by the Institutional Review Board and conducted in compliance with Health Insurance Portability and Accountability Act (HIPAA) regulations.
The neurological examination, MRN findings (including level of disease), interval from onset of symptoms to MRN, EMG/NCS findings (including localization of disease), interval from onset of symptoms to EMG/NCS, consistency of MRN results with EMG/NCS data, operative findings, and biopsy or pathological results were obtained or determined retrospectively for each patient by review of the medical records.
Magnetic Resonance Neurography
To obtain MR neurograms, STIR images were acquired in coronal and axial planes through the region of concern utilizing phased array body and surface coils on a Siemens or Philips 1.5-T magnet. The following parameters were used: TR = 2530 msec, TE = 20 msec, TI = 160, a 34-cm field of view, and number of excitations = 3. Axial volumetric 3D DESS sequences were also obtained in some patients to reformat the images in multiple planes. The DESS sequence has increased sensitivity to water content changes and abnormal T2 signal. For the DESS sequence the parameters used were: TR = 25 msec, TE = 9 msec, flip angle = 35°, field of view = 8-10 cm, matrix size 256 × 256.
Statistical Analysis
Data analysis was performed with commercially available software (SPSS version 11.0). Statistical tests included chi-square tests. Mean values are presented ± SDs.
Results
One hundred and seven male and 84 female patients with a mean age of 49 ± 16 years (range 5-84 years) underwent MRN evaluation. Diagnoses rendered with MRN included peripheral mononeuropathy (sciatic, ulnar, median, radial, anterior tibial, common peroneal, femoral, and lateral femoral cutaneous nerves; Fig. 1 ), radiculopathy ( Fig. 2) , brachial plexopathy (Figs. 3 and 4), tumor ( Fig. 5) , traumatic avulsion/neuroma (Fig. 6) , amyotrophic lateral sclerosis, and normal results ( Table  1) . The most common diagnoses were radiculopathy (in 31% of patients), peripheral neuropathy (19%), and brachial plexopathy (in 12%). Results were normal in 23%. Radiculopathies were evaluated most frequently in the cervical and lumbar regions (58 and 38%, respectively). Peripheral mononeuropathies most commonly involved the sciatic nerve (in 61% of patients).
Magnetic resonance neurograms were obtained at a median of 12 months (mean 29.7 months, range 0.25-432 Fig. 1 . Axial (A) and coronal (B) 3D DESS images obtained in a 34-year-old man with ulnar neuropathy. The patient presented with right hand pain and numbness in the ulnar distribution after an elbow joint arthroscopy; EMG/NCS showed right ulnar nerve injury, and MRN of the arm showed a diffusely abnormal ulnar nerve extending from 7 cm cephalad to 11 cm caudal to the medial condyle. The nerve was intact but enlarged, and had abnormal increased T2 signal. The patient subsequently underwent ulnar nerve transposition with improvement in his symptoms. Arrows indicate the ulnar nerve. Fig. 3 . Coronal, Gd-enhanced T1-weighted MR (A) and coronal STIR (B) images obtained in a 42-year-old woman with radiation plexopathy and a history of right apical hemangiosarcoma after resection and radiation therapy 6 years previously. She presented with tingling in the right shoulder and arm. Electromyography/NCS showed a mixed demyelinative and axonopathic process involving the entire brachial plexus, and MRN showed a resection cavity/operative site adjacent to enlarged right C-5, C-6, and C-7 roots and upper and middle trunks, with increased STIR signal and no significant contrast enhancement, suggestive of radiation change. The patient's clinical symptoms and radiographic findings have remained stable at follow-up.
Fig. 2.
Images obtained in a 74-year-old man with radiculopathy who presented with right arm pain, numbness in the thumb and index finger, deltoid, biceps, and triceps weakness 5 months after cervical laminectomy and foraminotomies at C4-7. Electromyography demonstrated C-5, C-6, and C-7 myotomal injuries with evidence of subacute denervation changes and chronic partial denervation with reinnervation. Axial CTs of the cervical spine revealed severe neuroforaminal narrowing at bilateral C4-5 (A), right C5-6 (B), and right C6-7 (C). Abnormal increased T2 signal was shown on MRN, and mild enlargement of the right C-6 root was seen on coronal (D) and axial (E) STIR images (arrows). The patient underwent reexploration surgery for right C4-5 and C5-6 foraminotomies with initial improvement in his symptoms followed by subsequent recurrence of symptoms. Repeated MRN performed 6 months after the second surgery showed a decrease in abnormal signal in the right C-6 root (coronal STIR image, F). However, there was a new finding of abnormal signal within the cord involving the dorsal gray matter on the right adjacent to the nerve root (axial STIR image, G) consistent with intramedullary edema or gliosis. months) after the onset of symptoms. The timing of MRN correlated with the likelihood of a positive MRN such that at an interval of ≤ 1 year, the fraction of negative MRNs was significantly smaller than that at > 1 year (0.18 vs 0.38; p = 0.009, Student t-test). Repeated MRN was performed at follow-up in 12 patients who did not undergo surgery ( Table 2 ). Of these, the results were unchanged in 7 (58%), showed a decrease in abnormal signal intensity in 4 (33%), and an increase in tumor size was observed in 1 patient (8%). In 3 of the 4 patients with a decrease in abnormal signal intensity, there was also an associated resolution of symptoms. Stable, persistent enlargement of the involved nerve was noted in the patient with persistent symptoms.
Of the 191 patients, 91 (48%) also underwent EMG/ NCS studies. Of these, 19 (21%) patients had > 1 EMG/ NCS study. The median interval from onset of symptoms to EMG/NCS was 8 months (mean 29.4 months, range 0.5-432 months). Sequential EMG/NCSs were unchanged in 11 patients (58%) apart from the expected natural evolution of chronic partial reinnervation from acute denervation. These EMG/NCSs were performed 24.1 ± 19.9 months (range 3-60 months) after symptom onset, with the interval between the first and last EMG/ NCS being 7.7 ± 8.2 months (range 1-24 months). There were 8 EMG/NCS studies (42%) with results that changed over time to reflect a different diagnosis (a change from radiculopathy to plexopathy or vice versa), a change from normal to abnormal, improvement, or deterioration. The changes in EMG/NCSs were initially detected 21.2 ± 18.4 months from the onset of symptoms with an interval of 8.6 ± 6.4 months from the first to last EMG/NCS study.
When MRN was compared with EMG/NCS, MRN was found to give the same information in 29 patients (32% ; Table 3 ), additional diagnostic information in 41 (45%), less in 15 (17%), and a different diagnosis in 6 (7%). In cases for which MRN provided less diagnostic information, no abnormality was shown or the area of abnormality was not included in the scan (for example, if the brachial plexus is imaged when the lesion is in the distal ulnar nerve), while EMG/NCS results indicated diagnoses including radiculopathy, brachial plexopathy, peripheral neuropathy, and anterior horn cell disorder. In these cases, the median interval from onset of symptoms to MRN and EMG/NCS was 27 and 26 months, respectively, with a median interval between MRN and EMG/NCS of 2 weeks. The differences in the results of MRN and EMG/NCS were independent of the interval between the 2 studies. Thus, MRN was least useful when obtained > 2 years from the onset of symptoms and when the wrong location was imaged.
The cases in which MRN provided more diagnostic information than EMG/NCS are shown in Table 3 . These cases are most informative in demonstrating the utility of MRNs-that is, when MRN should be obtained and how MRN affects management and/or diagnosis. Magnetic resonance neurography is useful in the following situations: 1) EMG/NCS and traditional MR imaging are both nondiagnostic for the suspected spinal nerve pathology (this happened in 1 of our patients); 2) EMG/NCS is nondiagnostic for suspected peripheral nerve lesion (6 patients); 3) when traditional MR imaging is ambiguous or shows multilevel disease and EMG/NCS is unable to clarify these results (15 patients); 4) when the patient cannot tolerate EMG/NCS (1 patient); 5) for localization of trauma of the brachial plexus or peripheral nerves (4 patients); 6) for localization of peripheral nerve lesions (1 patient); 7) in patients who have received radiation therapy to the brachial plexus region presenting with brachial plexopathy (5 patients); and 7) in patients with peripheral and spinal nerve tumors (8 patients) (Table 4) .
Patients with nondiagnostic EMG/NCS and/or MR imaging results benefitted from MRN in terms of diagnosis and localization. Patients with ambiguous MR imaging or EMG/NCS results that were nondiagnostic or inconsistent with imaging results not only benefitted in terms of diagnosis, but also had their treatment plan altered (surgery offered/done in 10, and surgery prevented in 3). Magnetic resonance neurography was also beneficial in obtaining a diagnosis in patients who could not tolerate EMG/NCSs, and MRN was useful in differentiating between radiation plexopathy and radiation-induced tumor in those who had previously undergone radiation therapy to the brachial plexus region. In our series, 1 of 5 such patients were found to have radiation-induced sarcoma of the brachial plexus; the diagnosis of such tumors is important for prognosis and treatment. Finally, MRN is useful for diagnosing and visualizing tumors, which cannot be done by EMG. Four peripheral nerve sheath tumors were demonstrated on MRN, 1 of which was on the distal sciatic nerve. Other tumors were found in patients with other systemic diseases (Gorham disease, infiltrative leukemia, metastatic breast cancer). When MRN provided more information than EMG, the median time from onset of symptoms to MRN and EMG/NCS was 9 and 7 months, respectively, with a median 1-week interval between MRN and EMG/NCS.
When MRN and EMG/NCS provided different information or diagnoses, EMG/NCS was more likely to demonstrate abnormalities in the distal peripheral nerves while MRN tended to reveal radiculopathy, plexopathy, or abnormalities of a different peripheral nerve. Both modalities were equally likely to correlate with clinical findings, however (Table 5 ). Disease management was based on the findings of the modality most consistent with clinical findings.
Magnetic resonance neurography was performed postoperatively in 21 patients who had either persistent or new symptoms (Table 6 ). Of these, in 16 patients (76%), the same nerves were involved as in the prior surgical procedure. Symptoms that arose from the same nerves were mainly the result of scar formation (24%), inflammation of the nerve roots (29%), or a compressive radiculopathy (24%) caused by nearby structures. The remaining 5 patients (25%) had findings involving other nerves which were consistent with peripheral neuropathy (in 2 patients), inflammation (in 2) or were normal (in 1). Of the 21 patients who underwent postoperative MRN, subsequent surgery was performed in 3 as a result of the findings. Of the 3 patients who underwent repeated surgery, 2 had had posterior cervical foraminotomies and 1 had initially undergone a lumbar discectomy. The second operation, performed after MRN, resulted in 1 repeated posterior cervical foraminotomy, 1 anterior cervical discectomy at the same level, and 1 anterior lumbar discectomy, partial vertebrectomy, and placement of a prosthetic disk at the same level. All 3 patients showed postoperative improvement after the second surgery.
Discussion
Spinal MR imaging is now the gold standard for anatomical imaging of radiculopathies caused by compression. Although extremity MR imaging has been used to visualize muscle and other soft tissue or skeletal tumors, 2,9,10 an imaging modality suitable for visualization of peripheral nerve abnormalities has not been previously available. Cervical spine MR imaging has been shown to predict 74% of surgically confirmed lesions. 8 Despite its utility, conventional MR imaging has 2 main limitations in the diagnosis of radiculopathy. First, there is a high rate of false positive examinations. Conventional cervical MR imaging reveals cervical disc disease in 20% of asymptomatic patients, and this increases with age; 1 the same is true for lumbar spine MR imaging. Wiesel and colleagues 13 found that 50% of asymptomatic patients older than 40 years of age had abnormal CTs of the lumbar spine. Second, there are many symptomatic cases with either normal MR images or radiological abnormalities at multiple levels, making a specific anatomical diagnosis and treatment plan difficult. Electromyography/NCS has traditionally been used to aid diagnosis by demonstrating and localizing physiological abnormalities attributable to individual nerve roots 5 when MR imaging results are nonlocalizing; EMG/NCS alone does not detect pure sensory nerve root injury. The combination of finding a dermatomal sensory deficit on neurological examination and obtaining normal sensory nerve conduction study results in the same distribution is indicative of sensory nerve root injury proximal to the respective dorsal root ganglion (typically a nerve root). Unfortunately, sensory nerve conduction studies are not available to assess the sensory function of all commonly affected nerve root injuries, particularly in older patients. Although diminished recruitment of motor units is immediately apparent after nerve tissue injury in clinically weak muscles assessed by needle EMG, other common findings of acute denervation (such as fibrillations or positive sharp waves) may not be present for up to 5 weeks after onset. The detection of diminished recruitment as the only EMG/NCS finding in patients with motor nerve tissue injury requires considerable skill on the part of the electromyographer. The earliest fibrillations detectable by needle EMG after nerve root injury occur 1-2 weeks after the onset of symptoms in the paraspinal muscles. More definitive diagnoses in the limbs can be made later after an interval of 2-6 weeks when fibrillations and positive waves develop. 12 In our series, 91 patients underwent both EMG/NCS and MRN, with MRN providing more information than EMG/NCSs in 41 patients (45%). Cases in which MRN provides more diagnostic information than EMG/NCS are important in determining the guidelines by which MRNs should be ordered and when they can be expected to be helpful. The most common scenario occurs when the traditional MR imaging and EMG/NCS results are inconclusive. In a typical clinical setting, MR images are often obtained as the first line of imaging for spinal nerve disease, followed by EMG/NCS if MR imaging results are inconclusive. Inconclusive MR images include those that demonstrate multilevel degenerative disease or disease at the suspected level but to a lesser degree than expected. The dilemma arises when the EMG/NCS does not confirm the clinical suspicion, either because it is negative, fails to localize the lesion, or localizes it to a different location. In such cases, MRN can serve as a useful diagnostic tool, the results of which can be used to determine the appropriateness of surgery.
The second most important group in whom MRN is useful are patients with tumors or systemic disease leading to tumors involving the peripheral and spinal nerves. We detected radiation-induced tumors in 20% of our patients with brachial plexus symptoms and a history of radiation therapy to the plexus. This high percentage may be the result of the referral bias of our practice and the small number of patients involved, but nevertheless illustrates an important aspect of MRN in detecting that which EMG/NCSs cannot. We also found MRN to be useful in 3 patients with metastatic tumors to the peripheral nerves from systemic diseases who had not undergone radiation therapy. Of these patients, 75% had tumor involvement of the brachial plexus. Magnetic resonance neurography is thus important in patients who present with brachial plexus symptoms who have a history of radiation or systemic tumors to search for metastatic tumors or radiationinduced tumors.
The third group in whom MRN can provide useful diagnostic and management information are those with traumatic injury to the peripheral nerves or with peripheral nerve lesions. In both types of patients, MRN provides visualization of the lesion that EMG cannot. The localization of neuromas and nerve avulsions is important in deciding on the feasibility of and planning the approach to surgical repair. Magnetic resonance neurography is also helpful for localizing the compression and assisting in surgical planning in patients with peripheral neuropathy (such as radial neuropathy). However, if surgery is not under consideration in such patients, then obtaining localization will not change the management or diagnosis. We conclude that MRNs are most useful in patients who have sustained traumatic injuries to the peripheral nerves or have peripheral neuropathies in whom surgical intervention is being considered.
In the majority of cases, MRN and EMG/NCS results were in agreement, and the combined anatomical and functional information obtained was complementary. Given the noninvasive nature of MRN, they represent a good alternative in patients who cannot tolerate EMG. The actual utility of MRN will need to be determined in a prospective study. Our series was inherently biased toward those patients whose other studies (MR imaging and EMG/NCS) were inconclusive. Magnetic resonance neurography was also informative postoperatively in patients in whom a prior compressive lesion was of concern. Among the 21 patients who underwent postoperative MRN, in > 75% an intrinsic pathological entity that did not warrant repeated operation but involved the same nerve tissue that had been decompressed surgically was revealed. The findings included scar formation, inflammation and edema, or arachnoiditis. Three patients underwent subsequent surgery as a result of the postoperative MRN. In 25% of postoperative cases, MRN revealed pathological entities that did not involve the nerve in question. These patients ultimately did not require another surgery. Magnetic resonance neurography can therefore be useful in the postoperative period for assessing the adequacy of the surgical decompression, possible need for additional surgery, or the presence of pathology in other nearby nerves. There were 6 cases in which MRN and EMG/NCS results provided different diagnoses (Table 5) . In these cases, MRN correlated with clinical findings in half of the cases while EMG/NCS was more consistent in the other half. These patients underwent treatment in accordance with the results of the diagnostic study that was most consistent with the clinical findings. In 15 patients, EMG/NCS provided the diagnosis while MRN was nondiagnostic. In 1 case, MRN missed the diagnosis because the wrong location was imaged. One must therefore recognize that MRN is limited in being able to image only a selected portion of the nervous pathway. Although EMGs can detect functional abnormalities along the entire distance of the peripheral nerve, MRN detects anatomical abnormalities in a specific, imaged region (such as brachial plexus or peripheral nerves, but not both at the same time).
The differences in MRN and EMG/NCS were not the result of differences in the timing of the tests, as the median interval between MRN and EMG/NCS was only 2 weeks when MRN was more diagnostic than EMG/NCS, and 1 week when MRN was less diagnostic than EMG/ NCS. The difference may be related to the timing of both examinations relative to the onset of symptoms; the median interval to MRN/EMG when MRN was more diagnostic was 9 months for MRN and 7 months for EMG compared with when MRN was less diagnostic at 27 months for MRN and 26 months for EMG. Moreover, when MRN was diagnostic, the studies were obtained at a median of 9 months from the onset of symptoms, while those that were not were obtained at a median of 20 months from the onset of symptoms. One may conclude that MRN is more likely to be useful when the onset of symptoms is within 1 year and less useful when the onset of symptoms is > 2 years prior to imaging.
Although Filler et al. 4 found a correlation between the degree of signal abnormality and the degree of functional recovery in crush nerve injuries, we did not find a correlation between nerve signal intensity and clinical outcome in our series. Of the 11 patients who underwent MRN multiple times, most showed no change in the preoperative nerve abnormalities seen on MRN, and only one-third had a decrease in the abnormal signal seen previously. Surprisingly, this decrease in abnormal signal observed did not correlate with clinical improvement. Among these patients, 75% reported worsening or persistent symptoms. This observation may be due to test selection bias, as patients who have persistent or worsening symptoms are much more likely to undergo repeated MRN. The decrease in signal abnormality did correlate with the interval being nearly twice as long (18 months) between MRN studies showing a decrease in signal abnormality compared with those that were unchanged (9 months), suggesting that the abnormal initial signal on MRN may decrease over time, independent of the clinical symptoms. This finding suggests that repeated MRN over long intervals may not be beneficial.
Conclusions
Magnetic resonance neurography is a novel, noninvasive means of acquiring detailed diagnostic anatomical information regarding peripheral nerve tissue injury. This anatomical information complements information regarding nerve function obtained from the clinical examination and EMG/NCS studies. In addition to providing accurate anatomical localization of a nerve injury, MRN is also useful for assessing proximal nerve tissue lesions, determining the size and imaging characteristics of mass lesions, and distinguishing residual mass effect or compression from unresolved inflammation or fibrosis in the postoperative patient. From our series, we found that MRN is most useful: 1) when traditional MR imaging and EMG/NCS results are inconclusive; 2) to exclude tumor in patients presenting with brachial plexopathy who have undergone radiation therapy to the brachial plexus region; 3) to rule out metastatic tumor in patients with brachial plexopathy with a history of systemic tumors; and 4) for surgical decision making or planning in patients with peripheral nerve trauma or lesions. We also conclude that MRN is limited in utility if the time from onset of symptoms is > 1 year, as well as by the possibility of imaging the wrong location along the course of the peripheral nerve. 
Disclaimer
